|
1
|
Shimizu D, Kanda M and Kodera Y: Review of
recent molecular landscape knowledge ofgastric cancer. Histol
Histopathol. 33:11–26. 2017.PubMed/NCBI
|
|
2
|
Daniyal M, Ahmad S, Ahmad M, Asif HM,
Akram M, Ur Rehman S and Sultana S: Risk factors and epidemiology
of gastric cancer in Pakistan. Asian Pac J Cancer Prev.
16:4821–4824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanda M and Kodera Y: Recent advances in
the molecular diagnostics of gastric cancer. World J Gastroenterol.
21:9838–9852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mu JS, Huang WD, Tan ZJ, Li ML, Zhang L,
Ding QC, Wu XS, Lu JH, Liu YB, Dong Q and Xu HN: Dopamine receptor
D2 is correlated with gastric cancer prognosis. Oncol Lett.
13:1223–1227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Emoto S, Ishigami H, Yamashita H,
Yamaguchi H, Kaisaki S and Kitayama J: Clinical significance of
CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
Gastric Cancer. 15:154–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanda M, Fujii T, Takami H, Suenaga M,
Inokawa Y, Yamada S, Nakayama G, Sugimoto H, Koike M, Nomoto S and
Kodera Y: Combination of the serum carbohydrate antigen 19-9 and
carcinoembryonic antigen is a simple and accurate predictor of
mortality in pancreatic cancer patients. Surg Today. 44:1692–1701.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yong H, Zhu H, Zhang S, Zhao W, Wang W,
Chen C, Ding G, Zhu L, Zhu Z, Liu H, et al: Prognostic value of
decreased expression of RBM4 in human gastric cancer. Sci Rep.
6:282222016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng ZQ: The present situation and future
of personalized medicine of precise medicine. Acta Universitatis
Medicinalis Nanjing. 11:1283–1284. 2016.
|
|
9
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsugane S and Sasazuki S: Diet and the
risk of gastric cancer: Review of epidemiologica evidence. Gastric
Cancer. 10:75–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanda M, Shimizu D, Sueoka S, Nomoto S,
Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, et
al: Prognostic relevance of SAMSN1 expression in gastric cancer.
Oncol Lett. 12:4708–4716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan JY, Huang X and Luo YL: PSMA7 inhibits
the tumorigenicity of A549 human lung adenocarcinoma cells. Mol
Cell Biochem. 366:131–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu XT, Chen W, Wang D, Shi QL, Zhang FB,
Liao YQ, Jin M and He C: The proteasome subunit PSMA7 located on
the 20q13 amplicon is overexpressed and associated with liver
metastasis in colorectal cancer. Oncol Rep. 19:441–446.
2008.PubMed/NCBI
|
|
14
|
Du H, Huang X, Wang S, Wu Y, Xu W and Li
M: PSMA7, a potential biomarker of diseases. Protein Pept Lett.
16:486–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pickart CM: Ubiquitin enters the new
millennium. Mol Cell. 8:499–504. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Glickman MH and Ciechanover A: The
ubiquitin-proteasome proteolytic pathway: Destruction for the sake
of construction. Physiol Rev. 82:373–428. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Groll M, Ditzel L, Löwe J, Stock D,
Bochtler M, Bartunik HD and Huber R: Structure of 20S proteasome
from yeast at 2.4 A resolution. Nature. 386:463–471. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Unno M, Mizushima T, Morimoto Y, Tomisugi
Y, Tanaka K, Yasuoka N and Tsukihara T: The structure of the
mammalian 20S proteasome at 2.75 A resolution. Structure.
10:609–618. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takagi K, Saeki Y, Yashiroda H, Yagi H,
Kaiho A, Murata S, Yamane T, Tanaka K, Mizushima T and Kato K:
Pba3-Pba4 heterodimer acts as a molecular matchmaker in proteasome
α-ring formation. Biochem Biophys Res Commun. 450:1110–1114. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomko RJ Jr and Hochstrasser M: Molecular
architecture and assembly of the eukaryotic proteasome. Annu Rev
Biochem. 82:415–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirano Y, Kaneko T, Okamoto K, Bai M,
Yashiroda H, Furuyama K, Kato K, Tanaka K and Murata S: Dissecting
beta-ring assembly pathway of the mammalian 20S proteasome. EMBO J.
27:2204–2213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ishii K, Noda M, Yagi H, Thammaporn R,
Seetaha S, Satoh T, Kato K and Uchiyama S: Disassembly of the
self-assembled, double-ring structure of proteasome α7
homo-tetradecamer by α6. Sci Rep. 5:181672015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang J, Kwong J, Sun EC and Liang TJ:
Proteasome complex as a potential cellular target of hepatitis B
virus X protein. J Virol. 70:5582–5591. 1996.PubMed/NCBI
|
|
24
|
Zhang Z, Torii N, Furusaka A, Malayaman N,
Hu Z and Liang TJ: Structural and functional characterization of
interaction between hepatitis B virus X protein and the proteasome
complex. J Biol Chem. 275:15157–15165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krüger M, Beger C, Welch PJ, Barber JR,
Manns MP and Wong-Staal F: Involvement of proteasome alpha-subunit
PSMA7 in hepatitis C virus internal ribosome entry site-mediated
translation. Mol Cell Biol. 21:8357–8364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Apcher GS, Heink S, Zantopf D, Kloetzel
PM, Schmid HP, Mayer RJ and Kruger E: Human immunodeficiency
virus-1 Tat protein interacts with distinct proteasomal alpha and
beta subunits. FEBS Lett. 553:200–204. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Semenza GL: O2-regulated gene expression:
Transcriptional control of cardiorespiratory physiology by HIF-1. J
Appl Physiol (1985). 96:1170–1172. 2004. View Article : Google Scholar
|
|
28
|
Tandle AT, Calvani M, Uranchimeg B, Zahavi
D, Melillo G and Libutti SK: Endothelial monocyte activating
polypeptide-II modulates endothelial cell responses by degrading
hypoxia- inducible factor-1alpha through interaction with PSMA7, a
component of the proteasome. Exp Cell Res. 315:1850–1859. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li D, Dong Q, Tao Q, Gu J, Cui Y, Jiang X,
Yuan J, Li W, Xu R, Jin Y, et al: c-Abl regulates proteasome
abundance by controlling the ubiquitin-proteasomal degradation of
PSMA7 subunit. Cell Rep. 10:484–496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ohnami S, Matsumoto N, Nakano M, Aoki K,
Nagasaki K, Sugimura T, Terada M and Yoshida T: Identification of
genes showing differential expression in antisense K-ras-transduced
pancreatic cancer cells with suppressed tumorigenicity. Cancer Res.
59:5565–5571. 1999.PubMed/NCBI
|
|
31
|
Richardson AL, Wang ZC, De Nicolo A, Lu X,
Brown M, Miron A, Liao X, Iglehart JD, Livingston DM and Ganesan S:
X chromosomal abnormalities in basal-like human breast cancer.
Cancer Cell. 9:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Romanuik TL, Wang G, Morozova O, Delaney
A, Marra MA and Sadar MD: LNCaP Atlas: Gene expression associated
with in vivo progression to castration-recurrent prostate cancer.
BMC Med Genomics. 3:432010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi YY, Wang HC, Yin YH, Sun WS, Li Y,
Zhang CQ, Wang Y, Wang S and Chen WF: Identification and analysis
of tumour-associated antigens in hepatocellular carcinoma. Br J
Cancer. 92:929–934. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scotto L, Narayan G, Nandula SV,
Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright
JD, Pothuri B, Mansukhani M and Murty VV: Identification of copy
number gain and overexpressed genes on chromosome arm 20q by an
integrative genomic approach in cervical cancer: Potential role in
progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu XT, Chen W, Zhang FB, Shi QL, Hu JB,
Geng SM and He C: Depletion of the proteasome subunit PSMA7
inhibits colorectal cancer cell tumorigenicity and migration. Oncol
Rep. 22:1247–1252. 2009.PubMed/NCBI
|
|
36
|
Honma K, Takemasa I, Matoba R, Yamamoto Y,
Takeshita F, Mori M, Monden M, Matsubara K and Ochiya T: Screening
of potential molecular targets for colorectal cancer therapy. Int J
Gen Med. 2:243–257. 2009.PubMed/NCBI
|
|
37
|
Edge SB and Carolyn CC: The American Joint
Committee on cancer: The 7th edition of the AJCC cancer staging
manualand the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bai J, Yong HM, Chen FF, Mei PJ, Liu H, Li
C, Pan ZQ, Wu YP and Zheng JN: Cullin1 is a novel marker of poor
prognosis and a potential therapeutic target in human breast
cancer. Ann Oncol. 24:2016–2022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang Q, Liu YF, Zhu XJ, Li YH, Zhu J,
Zhang JP, Feng ZQ and Guan XH: Expression and prognostic
significance of the alpha B-crystallin gene in human hepatocellular
carcinoma. Hum Pathol. 40:300–305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao W, Zhu H, Zhang S, Yong H, Wang W,
Zhou Y, Wang B, Wen J, Qiu Z, Ding G, et al: Trop2 is overexpressed
in gastric cancer and predicts poor prognosis. Oncotarget.
7:6136–6145. 2016.PubMed/NCBI
|
|
42
|
Chen C, Wang X, Huang X, Yong H, Shen J,
Tang Q, Zhu J, Ni J and Feng Z: Nicotinamide N-methyltransferase: A
potential biomarker for worse prognosis in gastric carcinoma. Am J
Cancer Res. 6:649–663. 2016.PubMed/NCBI
|
|
43
|
D'Errico M, de Rinaldis E, Blasi MF, Viti
V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D,
et al: Genome-wide expression profile of sporadic gastric cancers
with microsatellite instability. Eur J Cancer. 45:461–469. 2009.
View Article : Google Scholar
|
|
44
|
Li Y, Huang J, Sun J, Xiang S, Yang D,
Ying D, Lu M, Li H and Ren G: The transcription levels and
prognostic values of seven proteasome alpha subunits in human
cancers. Oncotarget. 8:4501–4519. 2017.PubMed/NCBI
|
|
45
|
Holmila R, Sklias A, Muller DC, Degli
Esposti D, Guilloreau P, McKay J, Sangrajrang S, Srivatanakul P,
Hainaut P, Merle P, et al: Targeted deep sequencing of plasma
circulating cell-free DNA reveals Vimentin and Fibulin 1 as
potential epigenetic biomarkers for hepatocellular carcinoma. PLoS
One. 12:e01742652017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang L, Tang Z, Zhang H, Kou W, Lu Z, Li
X, Li Q and Miao Z: PSMA7 directly interacts with NOD1 and
regulates its function. Cell Physiol Biochem. 31:952–959. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu X, Huang W, Li C, Li P, Yuan J, Li X,
Qiu XB, Ma Q and Cao C: Interaction between c-Abl and Arg tyrosine
kinases and proteasome subunit PSMA7 regulates proteasome
degradation. Mol Cell. 22:317–327. 2006. View Article : Google Scholar : PubMed/NCBI
|
